Genomic Predictors Associated With Exceptional Response to Systemic Therapy in Advanced Pancreatic Cancer
BySuneel D. Kamath, MD,Joanna Roopkumar, MD,Ying Ni, PhD,Minqian Shen, MD, PhD,Pablo Bejarano, MD,Daniela Allende, MD,Arun Nagarajan, MD,Tim Nguyen, MD,Bachar Dergham, MD,Dale Shepard, MD, PhD,Marc A. Shapiro, MD,Michael J. McNamara, MD,Bassam N. Estfan, MD,Kanika G. Nair, MD,Alok A. Khorana, MD
Published: | Updated:
Suneel K. Kamath, MD, et al investigated exceptional responders and the correlation of nonsynonymous mutations for patients with advanced pancreatic cancer.
